Health-care companies fell as traders fled high-risk niches such as biotech and obesity-drug makers.

Shares of Novo Nordisk, Viking Therapeutics and Eli Lilly declined even after European drug regulators said one of the drugs, Wegovy, showed no sign of causing suicidal ideation.

Write to Rob Curran at

(END) Dow Jones Newswires

04-12-24 1725ET